The intricate nature of spinal surgery demands unprecedented precision to avoid severe complications such as nerve damage and paralysis. Recent advancements have steered spinal surgery towards robotic assistance, which enhances precision beyond human capabilities. These robotic systems allow for detailed pre-operative planning and real-time guidance during surgery, significantly reducing the margin for error and promoting the adoption of minimally invasive techniques. This review aims to evaluate the application of robotic systems in spinal surgeries, focusing on the accuracy and efficacy of these technologies in clinical settings. The authors utilized comprehensive literature searches in databases such as PubMed and Scopus, focusing on terms like "robot," "robot-assisted," and "spine surgery." The search was aimed at gathering both original research and review articles to assess the current status and advancements in robotic spinal surgery. Robotic systems, such as the Mazor X Stealth, have demonstrated high precision in pedicle screw placement with minimal deviation. Studies show a significant increase in the accuracy of screw placement compared to traditional methods. Furthermore, the use of robotic assistance in surgery has been linked to reduced operative times, less blood loss, and decreased radiation exposure to both patients and surgical teams. Robotic systems significantly enhance the precision and safety of spinal surgeries. They reduce the risk of complications, minimize surgical invasiveness, and maintain or improve operative outcomes. However, challenges such as high costs and the need for specialized training persist. Continuous technological advancements and training are essential for the broader adoption of these systems in spinal surgeries.
Background and Objectives: In case of the ineffectiveness of pharmacological and non-pharmacological treatments in managing chronic neuropathic pain, spinal cord stimulation (SCS) with BurstDR™ stimulation may reduce pain and increase the quality of life. The term “burst” refers to a series of stimulation impulses that are compressed into small packets and separated by intervals of latency. Materials and Methods: A group of 30 consecutive patients who received the BurstDR™ stimulator using the minimally invasive percutaneous method was selected. Patients selected for our study underwent numerous spinal surgeries before SCS implantation. In the study, analgesics and co-analgesics and their doses used by patients before and 6 months after SCS implantation were examined and compared. Using the visual analogue scale (VAS), pain was compared before and after the procedure. Patients` quality of life was assessed using the Oswestry Disability Index (ODI). Results: We observed a significant reduction in opioid daily doses by an average of 32.4% (±36.1%) and a reduction in paracetamol daily doses by an average of 40% (±33.4%). There was a reduction in pregabalin doses as well. Ketoprofen daily dose reduction was 85.4 mg. The mean VAS difference before and after procedure was 3.9 (±2.3), and the mean difference in ODI was 12.9 (±9), which benefits operative treatment. The VAS and ODI results were statistically significant as well. Conclusions: According to our research, BurstDR™ stimulation improves the quality of life by reducing doses of analgesics and the level of pain.
COVID-19 has affected the entire world and has had a great impact on healthcare, influencing the treatment of patients with acute ischemic stroke (AIS). The aim of this study was to determine the impact of the COVID-19 pandemic on the care of patients with AIS. We performed a retrospective analysis of 1599 patients diagnosed with AIS and hospitalized in the authors’ institution from January 2018 to December 2021. The final sample consisted of 265 patients treated with thrombolysis without a diagnosis of COVID-19. The initiation of thrombolytic treatment during the pandemic was delayed (2:42 ± 0:51 vs. 2:25 ± 0:53; p = 0.0006). The delay was mainly related to the pre-hospital phase (1:41 ± 0:48 vs. 1:26 ± 0:49; p = 0.0014), and the door-to-needle time was not affected. There were no differences in stroke severity and patients’ outcomes. Patients with AIS were less likely to have previously been diagnosed with atrial fibrillation (16.9% vs. 26.7%; p = 0.0383), ischemic heart disease (25.3% vs. 46.5%; p = 0.0003) and hyperlipidemia (31.2% vs. 46.5%; p = 0.0264). Patients treated during the pandemic had higher glycemia (149.45 ± 54. vs. 143.25 ± 60.71 mg/dL; p= 0.0012), while no significant differences in their lipid profiles were found. Conclusions: The COVID-19 pandemic affected the treatment of AIS patients locally at our stroke center. It caused treatment delay and hindered the recognition of risk factors prior to the occurrence of AIS.
Background and Objectives: As brain lesions present complex diagnostic challenges, accurate tissue sampling via biopsy is critical for effective treatment planning. Traditional frame-based stereotactic biopsy has been complemented by navigated biopsy techniques, leveraging advancements in imaging and navigation technology. This study aims to compare the navigated and frame-based stereotactic biopsy methods in a clinical setting, evaluating their efficacy, safety, and diagnostic outcomes to determine the optimal approach for precise brain lesion targeting. Materials and Methods: retrospective analysis was conducted on patients who underwent brain biopsies between January 2017 and August 2023 at an academic medical center. Data on patient demographics, clinical characteristics, biopsy technique (navigated vs. frame-based), and outcomes including accuracy, complications, and hospital stay duration were analyzed. Results: The cohort comprised 112 patients, with no significant age or gender differences between groups. Symptoms leading to biopsy were predominantly diminished muscle strength (42.0%), cognitive issues (28.6%), and aphasia (24.1%). Tumors were most common in the deep hemisphere (24.1%). The median hospital stay was 5 days, with a rehospitalization rate of 27.7%. Complications occurred in 4.47% of patients, showing no significant difference between biopsy methods. However, navigated biopsies resulted in fewer samples (p < 0.001) but with comparable diagnostic accuracy as frame-based biopsies. Conclusions: Navigated and frame-based stereotactic biopsies are both effective and safe, with comparable accuracy and complication rates. The choice of technique should consider lesion specifics, surgeon preference, and technological availability. The findings highlight the importance of advanced neurosurgical techniques in enhancing patient care and outcomes.
15 October 2024 in Annales Academiae Medicae Silesiensis
WPROWADZENIE: W ostatnim czasie obserwuje się wzrost liczby opublikowanych artykułów dotyczących sztucznej inteligencji w dziedzinie medycyny, szczególnie w obszarze neurochirurgii. Badania dotyczące integracji sztucznej inteligencji z praktyką neurochirurgiczną wskazują na postępującą zmianę w kierunku szerszego wykorzystania narzędzi wspomaganych sztuczną inteligencją w diagnostyce, analizie obrazu i podejmowaniu decyzji.MATERIAŁ I METODY: W badaniu oceniono efektywność ChatGPT-3.5 i ChatGPT-4 na Państwowym Egzaminie Specjalizacyjnym (PES) z neurochirurgii przeprowadzonym jesienią 2017 r., który w czasie przeprowadzania badania był najnowszym dostępnym na stronie Centrum Egzaminów Medycznych (CEM) egzaminem z oficjalnie udostępnionymi odpowiedziami. Próg zdawalności egzaminu specjalizacyjnego wynosi 56% poprawnych odpowiedzi. Egzamin składał się ze 116 pytań jednokrotnego wyboru, po wyeliminowaniu czterech z uwagi na ich niezgodność z aktualną wiedzą. Ze względu na poruszane zagadnienia pytania podzielono na dziesięć grup tematycznych. Na potrzeby gromadzenia danych obie wersje ChatGPT zostały poinformowane o zasadach egzaminu i poproszone o ocenę stopnia pewności co do każdej odpowiedzi w skali od 1 (zdecydowanie niepewny) do 5 (zdecydowanie pewny). Wszystkie interakcje odbywały się w języku polskim i były rejestrowane.WYNIKI: ChatGPT-4 wyraźnie przewyższył ChatGPT-3.5 z różnicą wynoszącą 29,4% (p < 0,001). W przeciwieństwie do ChatGPT-3.5, ChatGPT-4 z sukcesem osiągnął próg zdawalności dla PES. W testach ChatGPT-3.5 i ChatGPT-4 odpowiedzi były takie same w 61 pytaniach (52,58%), w obu przypadkach były poprawne w 28 pytaniach (24,14%) i niepoprawne w 33 pytaniach (28,45%).WNIOSKI: ChatGPT-4 osiąga większą poprawność w udzielanych odpowiedziach w porównaniu z ChatGPT-3.5, prawdopodobnie dzięki zaawansowanym algorytmom i szerszemu zbiorowi danych treningowych, co podkreśla lepsze zrozumienie złożonych koncepcji neurochirurgicznych.
1 January 2024 in Postępy Higieny I Medycyny Doświadczalnej
Introduction: Artificial intelligence (AI) has evolved significantly, driven by advancements in computing power and big data. Technologies like machine learning and deep learning have led to sophisticated models such as GPT-3.5 and GPT-4. This study assesses the performance of these AI models on the Polish National Specialty Exam in ophthalmology, exploring their potential to support research, education, and clinical decision-making in healthcare. Materials and Methods: The study analyzed 98 questions from the Spring 2023 Polish NSE in Ophthalmology. Questions were categorized into five groups: Physiology & Diagnostics, Clinical & Case Questions, Treatment & Pharmacology, Surgery, and Pediatrics. GPT-3.5 and GPT-4 were tested for their accuracy in answering these questions, with a confidence rating from 1 to 5 assigned to each response. Statistical analyses, including the Chi-squared test and Mann-Whitney U test, were employed to compare the models’ performance. Results: GPT-4 demonstrated a significant improvement over GPT-3.5, correctly answering 63.3% of questions compared to GPT-3.5’s 37.8%. GPT-4’s performance met the passing criteria for the NSE. The models showed varying degrees of accuracy across different categories, with a notable gap in fields like surgery and pediatrics. Conclusions: The study highlights the potential of GPT models in aiding clinical decisions and educational purposes in ophthalmology. However, it also underscores the models’ limitations, particularly in specialized fields like surgery and pediatrics. The findings suggest that while AI models like GPT-3.5 and GPT-4 can significantly assist in the medical field, they require further development and fine-tuning to address specific challenges in various medical domains.